Loading...
Indian Pharmaceutical Exporter · #6 for Sulfadoxine · $400.0K export value · DGFT Verified
Laborate Pharmaceuticals India Ltd is the #6 Indian exporter of Sulfadoxine with $400.0K in export value and 8 verified shipments. Laborate Pharmaceuticals India Ltd holds a 2.2% market share in Sulfadoxine exports across 1 countries.
| $800.0K |
| 16 |
| 7.6% |
| BURKINA FASO | $650.0K | 13 | 6.1% |
| SENEGAL | $550.0K | 11 | 5.2% |
| CAMEROON | $450.0K | 9 | 4.3% |
| PAPUA NEW GUINEA | $400.0K | 8 | 3.8% |
| MOZAMBIQUE | $350.0K | 7 | 3.3% |
India exports Sulfadoxine to 38 countries. The top destination is NIGERIA (19.4%), followed by BELGIUM and CONGO DR.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SHALINA HEALTHCARE SARL | TANZANIA | $839.8K | 44 |
| EMBASSY PHARMACEUTICAL AND | NIGERIA | $400.0K | 8 |
| ERRA | GHANA | $250.0K | 5 |
| UNDP CHAD | CHAD | $200.0K | 4 |
| BORNEO PACIFIC PHARMACEUTICALS LTD | PAPUA NEW GUINEA | $100.0K | 2 |
| CATHOLIC RELIEF SERVICES (CRS) | GUINEA | $100.0K | 2 |
| M/S. THE DIRECTOR GENERAL. | TANZANIA | $100.0K | 2 |
| PROGRAMME NATIONAL DE LUTTE | COTE D IVOIRE | $100.0K | 2 |
| UNITE DE GESTION DES PROJETS (UGP) | CAMEROON | $100.0K | 2 |
| UNDP GUINEA BISSAU | GUINEA BISSAU | $100.0K | 2 |
India's Sulfadoxine is purchased by 74 buyers worldwide. The top buyer is SHALINA HEALTHCARE SARL (TANZANIA), followed by EMBASSY PHARMACEUTICAL AND and ERRA.
India exported $11.4M worth of Sulfadoxine through 364 shipments from 41 suppliers to 38 countries, serving 74 buyers globally. Laborate Pharmaceuticals India Ltd contributes $400.0K to this total, accounting for 2.2% of India's Sulfadoxine exports.
Laborate Pharmaceuticals India Ltd's average Sulfadoxine shipment value is $50.0K per consignment, based on 8 shipments totaling $400.0K.
Laborate Pharmaceuticals India Ltd ranks #6 among 41 Indian Sulfadoxine exporters with a 2.2% market share. The top 3 exporters are S KANT HEALTHCARE LIMITED ($5.2M), MACLEODS PHARMACEUTICALS LTD ($1.7M), GRACURE PHARMACEUTICALS LIMITED ($1.6M). Laborate Pharmaceuticals India Ltd processed 8 shipments to 1 destination countries.
What Laborate Pharmaceuticals India Ltd must comply with to export Sulfadoxine to its top destination countries
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | MEDOPHARM | $600.0K | 12 | 4 | $50.0K |
| 7 | SHALINA LABORATORIES PRIVATE LIMITED | $574.8K | 38 | 9 | $15.1K |
| 6 | LABORATE PHARMACEUTICALS INDIA LTD ★ | $400.0K | 8 | 1 | $50.0K |
| 8 | MEDOPHARM PRIVATE LIMITED | $262.7K | 14 | 1 | $18.8K |
| 9 | SHALINA LABORATORIES PVT LTD | $170.2K | 5 | 3 | $34.0K |
Laborate Pharmaceuticals India Ltd ranks #6 among 41 Indian Sulfadoxine exporters. Average shipment value of $50.0K compared to the market average of $279.0K. The closest competitors by value are MEDOPHARM and SHALINA LABORATORIES PRIVATE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 69 | 19.0% |
| JNPT/ NHAVA SHEVA SEA | 51 | 14.0% |
| JNPT | 37 | 10.2% |
| NHAVA SHEVA | 32 | 8.8% |
| PATLI ICD (INPTL6) | 20 | 5.5% |
| SAHAR AIR | 18 | 4.9% |
| CHENNAI SEA (INMAA1) | 13 | 3.6% |
| KAMARAJAR PORT (INENR1) | 11 | 3.0% |
Latest developments and market context
Detailed market intelligence for Sulfadoxine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 38+ countries, 74+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Laborate Pharmaceuticals India Ltd's Sulfadoxine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Laborate Pharmaceuticals India Ltd
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Laborate Pharmaceuticals India Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sulfadoxine. For current shipment-level data, contact TransData Nexus.